Cristina Capanni Selected Research

Laminopathies

1/2020	Lamin A involvement in ageing processes.
1/2019	Statins and Histone Deacetylase Inhibitors Affect Lamin A/C - Histone Deacetylase 2 Interaction in Human Cells.
1/2019	Ankrd2 in Mechanotransduction and Oxidative Stress Response in Skeletal Muscle: New Cues for the Pathogenesis of Muscular Laminopathies.
9/2014	Diverse lamin-dependent mechanisms interact to control chromatin dynamics. Focus on laminopathies.
4/2011	Laminopathies and lamin-associated signaling pathways.
1/2011	Muscular laminopathies: role of prelamin A in early steps of muscle differentiation.
7/2010	Lamin A precursor induces barrier-to-autointegration factor nuclear localization.
2/2008	Drugs affecting prelamin A processing: effects on heterochromatin organization.
1/2008	SREBP1 interaction with prelamin A forms: a pathogenic mechanism for lipodystrophic laminopathies.
1/2007	A pathogenic mechanism leading to partial lipodistrophy and prospects for pharmacological treatment of insulin resistance syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristina Capanni Research Topics

Disease

15	Laminopathies 01/2020 - 05/2005
8	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 01/2020 - 04/2003
7	Progeria (Hutchinson Gilford Syndrome) 01/2020 - 09/2009
6	Lipodystrophy 01/2021 - 06/2005
6	Familial Partial Lipodystrophy (Dunnigan Syndrome) 10/2012 - 11/2003
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2014 - 05/2005
3	Werner Syndrome (Werner's Syndrome) 07/2010 - 06/2005
2	Neoplasms (Cancer) 04/2022 - 01/2021
2	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2008
2	Autosomal Emery-Dreifuss Muscular Dystrophy 01/2019 - 01/2017
2	Chromosomal Instability (Chromosome Stability) 01/2014 - 10/2013
2	Fanconi Anemia (Fanconi's Anemia) 01/2014 - 10/2013
2	Rare Diseases (Rare Disease) 07/2011 - 09/2009
1	Ewing Sarcoma (Sarcoma, Ewing) 04/2022
1	Carcinogenesis 01/2021
1	Kyphosis 01/2021
1	Inflammation (Inflammations) 01/2020
1	Bone Resorption 10/2015
1	Atherosclerosis 10/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014
1	Bone Marrow Failure Disorders 01/2014
1	Hypersensitivity (Allergy) 10/2013
1	Cardiomyopathies (Cardiomyopathy) 06/2012
1	Osteolysis 07/2011
1	Muscular Dystrophies (Muscular Dystrophy) 04/2011
1	Heart Arrest (Cardiac Arrest) 11/2010
1	Cytomegalovirus Infections (Inclusion Disease) 03/2008
1	Infections 03/2008
1	Insulin Resistance 01/2007
1	Scleroatonic muscular dystrophy 01/2006
1	Muscular Diseases (Myopathy) 12/2003
1	Miyoshi myopathy 12/2003
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 12/2003

Drug/Important Bio-Agent (IBA)

20	Lamin Type A (Lamin A)IBA 04/2022 - 04/2003
12	prelamin AIBA 01/2020 - 06/2005
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2003
7	LaminsIBA 01/2019 - 11/2003
4	emerinIBA 01/2020 - 04/2003
4	ChromatinIBA 03/2016 - 10/2005
3	CytokinesIBA 01/2014 - 10/2013
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 04/2011
2	HeterochromatinIBA 10/2015 - 01/2007
2	Lamin Type B (Lamin B)IBA 04/2011 - 03/2008
1	tocilizumab (atlizumab)FDA Link 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 03/2016
1	Sirolimus (Rapamycin)FDA Link 10/2015
1	Histones (Histone)IBA 10/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2015
1	VimentinIBA 10/2013
1	Biological ProductsIBA 07/2011
1	lamina-associated polypeptide 2IBA 04/2011
1	Peptides (Polypeptides)IBA 04/2011
1	Nuclear Matrix-Associated ProteinsIBA 04/2011
1	Protein PrecursorsIBA 07/2010
1	Viral ProteinsIBA 03/2008
1	NF-kappa B (NF-kB)IBA 01/2008
1	Complementary DNA (cDNA)IBA 01/2008
1	CollagenIBA 01/2006
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2005
1	PPAR gammaIBA 06/2005
1	Nuclear Proteins (Protein, Nuclear)IBA 05/2005
1	DysferlinIBA 12/2003

Therapy/Procedure

2	Therapeutics 10/2015 - 02/2008
1	Induced Heart Arrest (Cardioplegia) 11/2010